BRIEF published on 06/30/2026 at 00:05, 4 months 13 days ago Kris Vervaet appointed CIO of the KBC Group Innovation Digital Transformation KBC Kris Vervaet Erik Luts
BRIEF published on 06/30/2026 at 00:05, 4 months 13 days ago KBC nomme Kris Vervaet au poste de nouveau directeur des systèmes d'information du groupe Transformation Numérique Groupe KBC Kris Vervaet Erik Luts Nomination Du Directeur Des Systèmes D'information
BRIEF published on 06/29/2026 at 23:51, 4 months 13 days ago 1933 Industries Reports Q3 2026 Financial Performance Cost Optimization Cannabis Market 1933 Industries Q3 2026 Financial Results Nevada Brand
BRIEF published on 06/29/2026 at 23:51, 4 months 13 days ago 1933 Industries publie ses résultats financiers du troisième trimestre 2026 Marché Du Cannabis Optimisation Des Coûts Industries De 1933 Résultats Financiers Du Troisième Trimestre 2026 Marque Nevada
BRIEF published on 06/29/2026 at 22:52, 4 months 13 days ago ABIVAX: Résultats prometteurs de l'essai ABTECT pour la rectocolite hémorragique Abivax Obefazimod Rectocolite Hémorragique Essai Clinique Sécurité
BRIEF published on 06/29/2026 at 22:52, 4 months 13 days ago ABIVAX: Promising results from the ABTECT trial for ulcerative colitis Security Abivax Obefazimod Ulcerative Colitis Clinical Trial
BRIEF published on 06/29/2026 at 22:10, 4 months 13 days ago ABIVAX : Résultats positifs pour l'obéfazimod dans la RCH réfractaire Abivax Obefazimod Essai Clinique Sécurité RCH Réfractaire
BRIEF published on 06/29/2026 at 22:10, 4 months 13 days ago ABIVAX: Positive results for obefazimod in refractory ulcerative colitis Security Abivax Obefazimod Clinical Trial Refractory Ulcerative Colitis
BRIEF published on 06/29/2026 at 22:10, 4 months 13 days ago Abivax Announces Positive Phase 3 Results for Obefazimod in Ulcerative Colitis Obefazimod Ulcerative Colitis Phase 3 Results Safety Profile Clinical Remission
BRIEF published on 06/29/2026 at 22:10, 4 months 13 days ago Abivax annonce des résultats positifs de phase 3 pour l'obefazimod dans la colite ulcéreuse Obefazimod Rectocolite Hémorragique Rémission Clinique Profil De Sécurité Résultats De La Phase 3
Published on 11/13/2026 at 10:40, 2 hours 44 minutes ago SouthGobi Announces Third Quarter 2026 Unaudited Financial and Operating Results
Published on 11/13/2026 at 09:00, 4 hours 24 minutes ago Touchstone Exploration Announces Third Quarter 2026 Results
Published on 11/13/2026 at 02:40, 10 hours 44 minutes ago Jaguar Mining Reports Third Quarter 2026 Results with 67% Growth in Adjusted Net Income and 46% Higher Adjusted EBITDA
Published on 11/13/2026 at 02:10, 11 hours 14 minutes ago Amarc to Participate in Consolidation of Aurora West Through Aurora Minerals LTD
Published on 11/12/2026 at 23:25, 13 hours 59 minutes ago Renegade Gold Announces Bought Deal Private Placement for Gross Proceeds of C$5 Million
Published on 11/13/2026 at 12:30, 53 minutes ago WIN SOURCE Highlights NEXUS™ at electronica 2026, Advancing Supply Chain Resilience
Published on 11/13/2026 at 12:30, 54 minutes ago Immunic, Inc. Reports Third Quarter 2026 Financial Results and Provides Corporate Update
Published on 11/13/2026 at 12:10, 1 hour 13 minutes ago Where Winds Meet 1st Anniversary Launches Today: New 'Hutuo' Region Puts the True Spirit of 'Xia' to the Test
Published on 11/13/2026 at 11:01, 2 hours 22 minutes ago Finnvera Group, Interim Management Statement 1 January–30 September 2026: Domestic and export financing granted increased year-on-year – Capital buffers will continue to support financing for growth, investments and exports
Published on 11/13/2026 at 10:34, 2 hours 49 minutes ago clearvise increases Revenue and Earnings in the third quarter and confirms 2026 full-year forecast
Published on 11/13/2026 at 11:35, 1 hour 48 minutes ago ENGIE and Google to partner on energy solutions for a potential data center project near Châteauroux, France
Published on 11/13/2026 at 11:35, 1 hour 48 minutes ago ENGIE et Google s’associent pour développer les solutions énergétiques d’un projet de data center envisagé près de Châteauroux, en France
Published on 11/13/2026 at 08:00, 5 hours 24 minutes ago Résultats trimestriels au 30 septembre 2026 - ANR par action : 101,54 €, en progression de + 7,8 % sur 9 mois - Capitaux propres consolidés : 772 M€
Published on 11/12/2026 at 23:12, 14 hours 11 minutes ago Belgrano continues the implementation of its public share buyback offer (OPRA)
Published on 11/12/2026 at 23:12, 14 hours 11 minutes ago Belgrano poursuit la mise en oeuvre de son projet d'OPRA
